Article Figures & Data
Figures
- Figure 1.
Representative sections of endometrial cancer with immunohistochemical staining of WT1. Strong cytoplasmic staining is observed in the invasion front of the tumor (×40; inset, ×200).
- Figure 2.
The Kaplan-Meier survival curves of 70 patients with endometrial carcinoma in relation to WT1 expression are shown. A, Relapse-free survival rate; B, overall survival rate.
Tables
In this issue
Jump to section
Related Articles
Cited By...
- Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients with Hematological Malignancies and Solid Tumors: Lessons from Early Clinical Trials
- WT1 Peptide Vaccine Stabilized Intractable Ovarian Cancer Patient for One Year: A Case Report
- Frequency of Myeloid Dendritic Cells Can Predict the Efficacy of Wilms' Tumor 1 Peptide Vaccination
- WT1 Expression Correlates with Angiogenesis in Endometrial Cancer Tissue
- Wilms' Tumor 1 (WT1) Peptide Immunotherapy for Gynecological Malignancy
- Correlation between WT1 Expression and Cell Proliferation in Endometrial Cancer